Degan Lu1, Yanru Qiao2, Karen C Johnson3, Junling Wang2. 1. a Department of Respiratory Medicine , Shandong Provincial Qianfoshan Hospital, Shandong University , Shandong , China. 2. b University of Tennessee College of Pharmacy , Memphis , TN , USA. 3. c Department of Preventive Medicine , University of Tennessee Health Science Center College of Medicine , Memphis , TN , USA.
Abstract
BACKGROUND: Asthma is one of the most frequently targeted chronic diseases in the medication therapy management (MTM) programs of the Medicare prescription drug (Part D) benefits. Although racial and ethnic disparities in meeting eligibility criteria for MTM services have been reported, little is known about whether there would be similar disparities among adults with asthma in the United States. METHODS: Adult patients with asthma (age ≥ 18) from Medical Expenditure Panel Survey (2011-2012) were analyzed. Bivariate analyses were conducted to compare the proportions of patients who would meet Medicare MTM eligibility criteria between non-Hispanic Blacks (Blacks), Hispanics and non-Hispanic Whites (Whites). Survey-weighted logistic regression was performed to adjust for patient characteristics. Main and sensitivity analyses were conducted to cover the entire range of the eligibility thresholds used by Part D plans in 2011-2012. RESULTS: The sample included 4,455 patients with asthma, including 2,294 Whites, 1,218 Blacks, and 943 Hispanics. Blacks and Hispanics had lower proportions of meeting MTM eligibility criteria than did Whites (P < 0.001). According to the main analysis, Blacks and Hispanics had 36% and 32% lower, respectively, likelihood of MTM eligibility than Whites (odds ratio [OR]: 0.64, 95% confidence interval [CI]: 0.45-0.90; OR: 0.68, 95% CI: 0.47-0.98, respectively). Similar results were obtained in sensitivity analyses. CONCLUSIONS: There are racial and ethnic disparities in meeting Medicare Part D MTM eligibility criteria among adult patients with asthma. Future studies should examine the implications of such disparities on health outcomes of patients with asthma and explore alternative MTM eligibility criteria.
BACKGROUND:Asthma is one of the most frequently targeted chronic diseases in the medication therapy management (MTM) programs of the Medicare prescription drug (Part D) benefits. Although racial and ethnic disparities in meeting eligibility criteria for MTM services have been reported, little is known about whether there would be similar disparities among adults with asthma in the United States. METHODS: Adult patients with asthma (age ≥ 18) from Medical Expenditure Panel Survey (2011-2012) were analyzed. Bivariate analyses were conducted to compare the proportions of patients who would meet Medicare MTM eligibility criteria between non-Hispanic Blacks (Blacks), Hispanics and non-Hispanic Whites (Whites). Survey-weighted logistic regression was performed to adjust for patient characteristics. Main and sensitivity analyses were conducted to cover the entire range of the eligibility thresholds used by Part D plans in 2011-2012. RESULTS: The sample included 4,455 patients with asthma, including 2,294 Whites, 1,218 Blacks, and 943 Hispanics. Blacks and Hispanics had lower proportions of meeting MTM eligibility criteria than did Whites (P < 0.001). According to the main analysis, Blacks and Hispanics had 36% and 32% lower, respectively, likelihood of MTM eligibility than Whites (odds ratio [OR]: 0.64, 95% confidence interval [CI]: 0.45-0.90; OR: 0.68, 95% CI: 0.47-0.98, respectively). Similar results were obtained in sensitivity analyses. CONCLUSIONS: There are racial and ethnic disparities in meeting Medicare Part D MTM eligibility criteria among adult patients with asthma. Future studies should examine the implications of such disparities on health outcomes of patients with asthma and explore alternative MTM eligibility criteria.
Authors: Meera Viswanathan; Leila C Kahwati; Carol E Golin; Susan J Blalock; Emmanuel Coker-Schwimmer; Rachael Posey; Kathleen N Lohr Journal: JAMA Intern Med Date: 2015-01 Impact factor: 21.873
Authors: Leslie A Shimp; Suzan N Kucukarslan; Jodie Elder; Tami Remington; Trisha Wells; Hae Mi Choe; Nancy J W Lewis; Duane M Kirking Journal: J Am Pharm Assoc (2003) Date: 2012
Authors: Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Pharm Health Serv Res Date: 2018-09-07
Authors: Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns Journal: Inquiry Date: 2018 Jan-Dec Impact factor: 1.730
Authors: Ivy O Poon; Felicia Skelton; Lena R Bean; Dominique Guinn; Terica Jemerson; Ngozi D Mbue; Creaque V Charles; Uche A Ndefo Journal: Pharmacy (Basel) Date: 2022-01-07
Authors: Christina A Spivey; Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Manag Care Spec Pharm Date: 2018-02